These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3352848)

  • 1. Plasma levels and loss of antithrombin III in chronic ambulatory peritoneal dialysis and nephrotic patients.
    Mori R; Triolo L; De Stefano V; Giusti BP; De Sole P; Leone G
    Nephron; 1988; 48(3):213-6. PubMed ID: 3352848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin III loss in patients with nephrotic syndrome or receiving continuous ambulatory peritoneal dialysis. Evidence of inactive antithrombin III in urine of patients with nephrotic syndrome.
    De Stefano V; Triolo L; De Martini D; Ferrelli R; Mori R; Leone G
    J Lab Clin Med; 1987 May; 109(5):550-5. PubMed ID: 3572202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein C, protein S, and antithrombin III levels in patients on continuous ambulatory peritoneal dialysis and hemodialysis.
    Lai KN; Yin JA; Yuen PM; Li PK
    Nephron; 1990; 56(3):271-6. PubMed ID: 2150218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and urinary heparin cofactor II levels in patients with nephrotic syndrome.
    Grau E; Oliver A; Félez J; Barceló P; Fernandez C; Ballarin JA; Fontcuberta J; Rutllant ML
    Thromb Haemost; 1988 Oct; 60(2):137-40. PubMed ID: 3217913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma and urinary antithrombin III in the nephrotic syndrome in adults].
    Antelin CH; Gouault-Heilmann M; Levent M; Bernard D; Ruszniewski P; Lagrue G
    Ann Med Interne (Paris); 1983; 134(8):713-6. PubMed ID: 6666909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of heparin and/or antithrombin III on intraperitoneal fibrin formation in continuous ambulatory peritoneal dialysis.
    Tabata T; Shimada H; Emoto M; Morita A; Furumitsu Y; Fujita J; Inoue T; Miki T; Nishizawa Y; Morii H
    Nephron; 1990; 56(4):391-5. PubMed ID: 2079997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High plasma levels of protein C activity and antigen in the nephrotic syndrome.
    Mannucci PM; Valsecchi C; Bottasso B; D'Angelo A; Casati S; Ponticelli C
    Thromb Haemost; 1986 Feb; 55(1):31-3. PubMed ID: 3754658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin III and the nephrotic syndrome.
    Jørgensen KA; Stoffersen E
    Scand J Haematol; 1979 May; 22(5):442-8. PubMed ID: 472663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of nitrogen balance in patients treated with continuous ambulatory peritoneal dialysis].
    Janaszak S; Grzegorzewska AE; Mariak I
    Pol Arch Med Wewn; 1998 Dec; 100(6):499-514. PubMed ID: 10405563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin III (AT III) and fibrinogen levels in nephrotic syndrome in children.
    Elidrissy AT; Gader AM
    Haemostasis; 1985; 15(6):384-8. PubMed ID: 4076845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal fibrin-formation and its inhibition in CAPD.
    Gries E; Paar D; Graben N; Bock KD
    Clin Nephrol; 1986 Oct; 26(4):209-12. PubMed ID: 3780071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of high levels of heparin cofactor II in the plasma and urine of adult patients with nephrotic syndrome.
    Toulon P; Gandrille S; Remy P; Chadeuf G; Jouvin MH; Aiach M
    Nephron; 1992; 60(2):176-80. PubMed ID: 1553002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte, plasma, urine and dialysate zinc levels in patients on continuous ambulatory peritoneal dialysis.
    Beerbower KS; Raess BU
    Am J Clin Nutr; 1985 Apr; 41(4):697-702. PubMed ID: 3984923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal protein losses in children with steroid-resistant nephrotic syndrome on continuous-cycler peritoneal dialysis.
    Kopanati S; Baum M; Quan A
    Pediatr Nephrol; 2006 Jul; 21(7):1013-9. PubMed ID: 16773415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome].
    Campo G; Modena N; Gallo A; Ciaffoni S
    Quad Sclavo Diagn; 1985 Mar; 21(1):106-16. PubMed ID: 2414802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antithrombin III in infantile nephrotic syndrome].
    Lorusso L; Miniello VL; Francioso G; Aceto G; DiBitonto G; Penza R
    Boll Soc Ital Biol Sper; 1982 Sep; 58(17):1093. PubMed ID: 7138678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis.
    Małyszko J; Małyszko JS; Myśliwiec M
    Kidney Blood Press Res; 2004; 27(2):71-7. PubMed ID: 14691349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intraperitoneal administration of heparin to patients on continuous ambulatory peritoneal dialysis (CAPD).
    Takahashi S; Shimada A; Okada K; Kuno T; Nagura Y; Hatano M
    Perit Dial Int; 1991; 11(1):81-3. PubMed ID: 2049431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Losses of 25-hydroxyvitamin D in peritoneal fluid: possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis.
    Aloni Y; Shany S; Chaimovitz C
    Miner Electrolyte Metab; 1983; 9(2):82-6. PubMed ID: 6601753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in peritoneal transport during continuous ambulatory peritoneal dialysis and its impact on ultrafiltration, loss of macromolecules and plasma level of proteins, lipids and lipoproteins.
    Kagan A; Bar-Khayim Y; Schafer Z; Fainaru M
    Nephron; 1993; 63(1):32-42. PubMed ID: 8446249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.